This business plan is designed to introduce our company to potential supplier partners, employers and investors. Zenergy Medical Industries, a start-up company, is initially focused on distribution of the most trusted therapeutic systems for residents of Homecare and assisted living facilities that are susceptible to complications from X. After establishing a market presence with this product niche, we will expand to offer other products related to further treating and managing complications of the disease.

The current market is poorly served by a network of local distributors and pharmacies. We will establish a national network, eventually spanning across the country, of clinical sales professionals. This will allow us to be the preferred partner in large, diverse, A.L. and Homecare markets. chains, and will make us attractive to potential supplier partners.

Potential Market

There are two main market opportunities: Assisted Living and Homecare residents who have the disease. There are an estimated 345,784 Homecare at risk residents, with a potential $59.6 million revenue, and an estimated 66,671 Assisted Living at risk residents, with a potential for $17.6 million in revenue.

Competitive Advantage

All market players have access to the product technology. We will be different by adding value through our distribution strategies and channels. Our extensive product lines make it extremely easy to work with. We have the unique ability to increase market share in this sector due to our corporate relationships, our ability build a regional field clinical sales team quickly and our ability develop compelling marketing programs. There is less competition from smaller local distributors and pharmacists, who do not approach the market in a coordinated or sophisticated manner.

Strategy

1. Establishing relationships with decision makers at major homecare chain companies will allow us to have exclusive access and sell into their facilities. This will enable us to offer ‘#8220’ pre-qualified sales opportunities to our clinical sales team.
2. Establishing a strong national sales team for clinical services capable of building strong relationships to clinical decision makers at facility level.
3. Marketing strategies and tactics that position us as leaders in providing clinical products solutions to assist facilities with managing the complications of illness.
4. To build a complete line of products to manage the complications of the disease, we will need to establish distribution relationships with top suppliers. As a cost-effective and efficient way for suppliers to enter the post-acute marketplace, we will establish an effective distribution channel that will be essential.

We will utilize the therapeutic system offering as the means to gain entrance into the market and build our organization. Then, we’ll add complementary products that manage the diseases. Next, there will be other products that deal with managing heart disease or aging.

Financial Summary

The business’s owners will make personal investments. We are seeking short-term (3 year) loans to help supplement initial cash flows from the sales in the first year. We expect a first year net income. This should grow substantialy by year three. By the end of year three, Zenergy Medical Industries will have a very respectable net worth.

Objectives

• To achieve the sales growth targets by month six and by end of year one. Aggressive gains in market share and average monthly revenues in year two.
• To increase the contracted sales team’s number to seven field clinic sales reps per month eight and 25 field clinic sales reps per year three.
• To achieve net profit in year one, increasing in year two, by containing costs and meeting sales goals.
• To begin paying Vice Presidents a regular salary starting in year two.
• To keep at least 98% customer satisfaction results after 90 days.

Mission

We offer post-acute services with products that help to manage complications of X diseases. These conditions can cause severe pain and suffering for patients.

Keys for Success

1. We offer a broad range of innovative and top quality products.
2. We offered unrivalled clinical support at a regional (national level) to post-acute facilities.
3. We are close to key decision-makers in the top post-acute chains and with clinicians and administrators at the facility level.
4. We are exceptional at communicating the value and benefits of our products, solutions, and brand in a strong, memorable and clear way.
5. We are a company with a unique spirit. People want to be part of our organization and do business with us. People can’t imagine working elsewhere once they join us.